Skip to main content

Boston Scientific braces for FDA review of anti-stroke device

Boston Scientific appears to face an uphill climb as it prepares for regulatory meetings concerning its Watchman device to protect against strokes, following the release of a new report that questions the efficacy of the product once it is implanted...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.